•Leads Frequency Therapeutics' development, validation and maintenance of biological assays•Maintains and executes drug screening integrity•Supports confocal microscopy and other evaluation techniquesAbout Frequency Therapeutics, Inc.Frequency Therapeutics is an innovative biotechnology start-up company co-founded by two world-renowned scientists: MIT Institute Professor Robert S. Langer, ScD, and Jeffrey Karp, PhD, Associate Professor at Brigham and Women’s Hospital, Harvard Medical School. Frequency Therapeutics’ platform technology, based on the co-founder’s discoveries in stem cell biology, has shown great promise in reversing sensory hearing loss, a potential $10 billion U.S. market in which no therapeutic solution exists. While hearing loss is the company’s initial focus, other potential applications include diabetes and gastrointestinal diseases.

Working with Chris Burd, PhD in the Cell Biology Department, studied the central role played by endosomal sorting in development and homeostasis of normal tissues.